{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:55:22Z","timestamp":1781135722993,"version":"3.54.1"},"reference-count":301,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154618","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T02:44:52Z","timestamp":1686624292000},"page":"154618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer"],"prefix":"10.1016","volume":"248","author":[{"given":"Alireza","family":"Azani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima Parvizi","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniyeh","family":"Ghasrsaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asra","family":"Idani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis kadkhodaei","family":"Eliaderani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Peirovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Dokhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad hassan","family":"Lotfalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadhadi mohammadzadeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoosh shahgholian","family":"Ghahfarokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"KarkonShayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa najari","family":"Hanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kardaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid Gholizadeh","family":"Navashenagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Abdolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Salmaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA: a Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.prp.2023.154618_bib3","article-title":"SEER cancer statistics review, 1975\u20132017","author":"Howlader","year":"2020","journal-title":"Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jnci\/djab122","article-title":"Association of the COVID-19 pandemic with patterns of statewide cancer services","volume":"114","author":"Yabroff","year":"2022","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"19","key":"10.1016\/j.prp.2023.154618_bib5","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1101\/gad.819500","article-title":"Molecular genetics of prostate cancer","volume":"14","author":"Abate-Shen","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154618_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7150\/jca.1.150","article-title":"Novel diagnostic biomarkers for prostate cancer","volume":"1","author":"Madu","year":"2010","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3892\/ijo.2020.5064","article-title":"MicroRNA\u2011137 regulates hypoxia\u2011mediated migration and epithelial\u2011mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR\/ERK signaling pathway.","volume":"57","author":"Zhang","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib8","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.3892\/ol.2016.5235","article-title":"HER2 gene amplification in patients with prostate cancer: evaluating a CISH-based method","volume":"12","author":"Sharifi","year":"2016","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib9","first-page":"749","article-title":"Molecular characterization of KRAS, BRAF, and EGFR genes in cases with prostatic adenocarcinoma; reporting bioinformatics description and recurrent mutations","volume":"61","author":"Salmaninejad","year":"2015","journal-title":"Clin. Lab"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr follow-up of the European randomized study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib12","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.febslet.2010.08.009","article-title":"Dysregulation of microRNAs in cancer: playing with fire","volume":"585","author":"Melo","year":"2011","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13277-014-2664-8","article-title":"AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy","volume":"36","author":"Zekri","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2023.154618_bib14","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"MicroRNAs and their potential for translation in prostate cancer. in","author":"White","year":"2009"},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/jca.6394","article-title":"Comprehensive microRNA profiling of prostate cancer","volume":"4","author":"Walter","year":"2013","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-82","article-title":"Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs","volume":"14","author":"Erdmann","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/pcan.2010.21","article-title":"The function of microRNAs, small but potent molecules, in human prostate cancer","volume":"13","author":"Sevli","year":"2010","journal-title":"Prostate Cancer prostatic Dis."},{"key":"10.1016\/j.prp.2023.154618_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101613","article-title":"MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer","volume":"28","author":"Ghamlouche","year":"2023","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/jpm11040296","article-title":"Blood-derived biomarkers of diagnosis, prognosis and therapy response in prostate cancer patients","volume":"11","author":"Bal\u00e1zs","year":"2021","journal-title":"J. Pers. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.cell.2009.11.030","article-title":"Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer","volume":"139","author":"Lin","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ijc.33344","article-title":"Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer","volume":"148","author":"M\u00f6ller","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib22","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.2741\/2312","article-title":"Chromosomal aberrations in prostate cancer","volume":"12","author":"Saramaki","year":"2007","journal-title":"Front Biosci."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-017-0206-6","article-title":"miRNAs associated with prostate cancer risk and progression","volume":"17","author":"Luu","year":"2017","journal-title":"BMC Urol."},{"issue":"19","key":"10.1016\/j.prp.2023.154618_bib24","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1038\/onc.2016.419","article-title":"MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer","volume":"36","author":"Bucay","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.31662\/jmaj.2021-0004","article-title":"Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer","volume":"4","author":"Shiota","year":"2021","journal-title":"JMA J."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib26","first-page":"3868","article-title":"Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics","volume":"13","author":"Allemailem","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib27","article-title":"PER3 polymorphisms and their association with prostate cancer risk in Japanese men","volume":"62","author":"Hinoura","year":"2021","journal-title":"J. Prev. Med. Hyg."},{"key":"10.1016\/j.prp.2023.154618_bib28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3389\/fcell.2020.622424","article-title":"Network and Pathway-Based Integrated Analysis Identified a Novel \u201crs28457673\u2013miR-15\/16\/195\/424\/497 Family\u2013IGF1R\u2013MAPK Signaling Pathway\u201d Axis Associated With Post-stroke Depression","volume":"8","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib29","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1261\/rna.1560209","article-title":"SNPs in human miRNA genes affect biogenesis and function","volume":"15","author":"Sun","year":"2009","journal-title":"Rna"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1158\/2159-8290.CD-14-1057","article-title":"A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer","volume":"5","author":"Stegeman","year":"2015","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mc.21973","article-title":"Genetic variants in the integrin gene predicted microRNA\u2010binding sites were associated with the risk of prostate cancer","volume":"53","author":"Liu","year":"2014","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib32","article-title":"SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers","volume":"18","author":"Preskill","year":"2013","journal-title":"Crit. Reviews\u2122 Oncog."},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/ijerph13111096","article-title":"MiRNAs and miRNA polymorphisms modify drug response","volume":"13","author":"Li","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1878-0261.12421","article-title":"Functional micro RNA binding site variants","volume":"13","author":"Yuan","year":"2019","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib35","first-page":"1873","article-title":"Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview","volume":"11","author":"Liu","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1724600821997461","article-title":"The role of single nucleotide polymorphisms of miRNAs 100 and 146a as prognostic factors for prostate cancer","volume":"36","author":"Camargo","year":"2021","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.prp.2023.154618_bib37","first-page":"14","article-title":"Inherited predisposition to prostate cancer: from gene discovery to clinical impact","volume":"128","author":"Cooney","year":"2017","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jcb.20696","article-title":"Prevalent mutations in prostate cancer","volume":"97","author":"Dong","year":"2006","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.prp.2023.154618_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4986365","article-title":"BRCA mutations in prostate cancer: prognostic and predictive implications","volume":"2020","author":"Messina","year":"2020","journal-title":"J. Oncol."},{"issue":"24","key":"10.1016\/j.prp.2023.154618_bib40","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4161\/cc.22852","article-title":"p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3","volume":"11","author":"Chappell","year":"2012","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107669","article-title":"Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress","volume":"31","author":"Nyquist","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib42","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1158\/1078-0432.CCR-06-2225","article-title":"Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer","volume":"13","author":"Kawamoto","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jnci\/dji010","article-title":"Epigenetic changes in prostate cancer: implication for diagnosis and treatment","volume":"97","author":"Li","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.prp.2023.154618_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-1804-1_7","article-title":"Prostate cancer epigenome","volume":"1238","author":"Chinaranagari","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12885-017-3252-2","article-title":"Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns","volume":"17","author":"Kirby","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41588-021-00969-x","article-title":"Genetic variation influencing DNA methylation provides insights into molecular mechanisms regulating genomic function","volume":"54","author":"Hawe","year":"2022","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03540-4","article-title":"Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers","volume":"5","author":"Sathyanarayanan","year":"2022","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"cell"},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2005.10.022","article-title":"Human RISC couples microRNA biogenesis and posttranscriptional gene silencing","volume":"123","author":"Gregory","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-007-0532-2","article-title":"MicroRNA\u2014implications for cancer","volume":"452","author":"Sassen","year":"2008","journal-title":"Virchows Arch."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr. Genom."},{"issue":"5755","key":"10.1016\/j.prp.2023.154618_bib53","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1126\/science.1121158","article-title":"The widespread impact of mammalian MicroRNAs on mRNA repression and evolution","volume":"310","author":"Farh","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"cell"},{"issue":"24","key":"10.1016\/j.prp.2023.154618_bib55","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.","volume":"17","author":"Yi","year":"2003","journal-title":"Genes Dev."},{"issue":"7051","key":"10.1016\/j.prp.2023.154618_bib56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Chendrimada","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions.","volume":"136","author":"Bartel","year":"2009","journal-title":"cell"},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib58","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrg3765","article-title":"Identification and consequences of miRNA\u2013target interactions\u2014beyond repression of gene expression","volume":"15","author":"Hausser","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.prp.2023.154618_bib60","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res."},{"issue":"7043","key":"10.1016\/j.prp.2023.154618_bib61","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"nature"},{"issue":"24","key":"10.1016\/j.prp.2023.154618_bib62","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/PPO.0b013e318250c001","article-title":"Causes and consequences of microRNA dysregulation","volume":"18","author":"Iorio","year":"2012","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib65","first-page":"17","article-title":"Epigenetic inactivation of microRNA gene hsa\u2010mir\u20109\u20131 in human breast cancer.","volume":"214","author":"Lehmann","year":"2008","journal-title":"J. Pathol. A J. Pathol. Soc. Gt. Br. Irel."},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib66","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","article-title":"Epigenetic silencing of microRNA-34b\/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer","volume":"68","author":"Toyota","year":"2008","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.prp.2023.154618_bib67","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008697","article-title":"Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells","volume":"5","author":"Vrba","year":"2010","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib69","first-page":"1343","article-title":"MicroRNAs that respond to histone deacetylase inhibitor SAHA and p53 in HCT116 human colon carcinoma cells","volume":"35","author":"Shin","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib70","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/ijc.24638","article-title":"Epigenetic regulation of microRNA expression in colorectal cancer","volume":"125","author":"Bandres","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib71","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","article-title":"Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells","volume":"9","author":"Saito","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e318164145e","article-title":"MicroRNAs","volume":"14","author":"Fabbri","year":"2008","journal-title":"Cancer J."},{"issue":"17","key":"10.1016\/j.prp.2023.154618_bib73","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1056\/NEJMp058190","article-title":"MicroRNAs as oncogenes and tumor suppressors","volume":"353","author":"Chen","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"46","key":"10.1016\/j.prp.2023.154618_bib74","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1038\/sj.onc.1209913","article-title":"A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes","volume":"25","author":"Kent","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1752-8062.2009.00110.x","article-title":"Applications of microRNA in cancer: exploring the advantages of miRNA","volume":"2","author":"Waldman","year":"2009","journal-title":"Clin. Transl. Sci."},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"issue":"22","key":"10.1016\/j.prp.2023.154618_bib77","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1073\/pnas.86.22.8867","article-title":"Activation of MYC in a masked t (8; 17) translocation results in an aggressive B-cell leukemia","volume":"86","author":"Gauwerky","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib78","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.prp.2023.154618_bib79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","article-title":"Current insights into the metastasis of epithelial ovarian cancer-hopes and hurdles","volume":"43","author":"Yousefi","year":"2020","journal-title":"Cell. Oncol."},{"issue":"21","key":"10.1016\/j.prp.2023.154618_bib80","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","article-title":"A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation","volume":"65","author":"Hayashita","year":"2005","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib81","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors","volume":"124","author":"Voorhoeve","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib82","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ijc.24827","article-title":"Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma","volume":"126","author":"Schaefer","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1158\/1541-7786.MCR-09-0443","article-title":"The microRNA profile of prostate carcinoma obtained by deep sequencing","volume":"8","author":"Szczyrba","year":"2010","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179113","article-title":"Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations","volume":"12","author":"Zedan","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib85","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s12094-020-02349-z","article-title":"Urinary microRNAs expression in prostate cancer diagnosis: a systematic review","volume":"22","author":"Paiva","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib86","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.25376","article-title":"Circulating miRNAs are correlated with tumor progression in prostate cancer","volume":"128","author":"Brase","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib87","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/pros.21276","article-title":"Androgen regulation of micro\u2010RNAs in prostate cancer","volume":"71","author":"Waltering","year":"2011","journal-title":"Prostate"},{"issue":"15","key":"10.1016\/j.prp.2023.154618_bib88","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1158\/0008-5472.CAN-08-0144","article-title":"Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.","volume":"68","author":"Ambs","year":"2008","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.prp.2023.154618_bib89","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1073\/pnas.0400400101","article-title":"Lessons from border cell migration in the Drosophila ovary: a role for myosin VI in dissemination of human ovarian cancer","volume":"101","author":"Yoshida","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib90","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/cgt.2008.77","article-title":"MicroRNA profile analysis of human prostate cancers","volume":"16","author":"Tong","year":"2009","journal-title":"Cancer gene Ther."},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib91","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","article-title":"MicroRNA expression profiling in prostate cancer","volume":"67","author":"Porkka","year":"2007","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib92","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/pros.20806","article-title":"GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus","volume":"68","author":"Wei","year":"2008","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib93","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2009.03.077","article-title":"MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells","volume":"383","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.prp.2023.154618_bib94","doi-asserted-by":"crossref","first-page":"11111","DOI":"10.1158\/0008-5472.CAN-07-2858","article-title":"MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy","volume":"67","author":"Weidhaas","year":"2007","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.prp.2023.154618_bib95","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","article-title":"MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells","volume":"65","author":"Chan","year":"2005","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib96","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1261\/rna.1034808","article-title":"MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis","volume":"14","author":"Yan","year":"2008","journal-title":"Rna"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-9-163","article-title":"Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.","volume":"9","author":"Qi","year":"2009","journal-title":"BMC Cancer"},{"issue":"6a","key":"10.1016\/j.prp.2023.154618_bib98","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1582-4934.2008.00533.x","article-title":"MicroRNA involvement in hepatocellular carcinoma","volume":"12","author":"Gramantieri","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib99","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.299.4.425","article-title":"MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma","volume":"299","author":"Schetter","year":"2008","journal-title":"Jama"},{"issue":"19","key":"10.1016\/j.prp.2023.154618_bib100","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","article-title":"miR-21-mediated tumor growth","volume":"26","author":"Si","year":"2007","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib101","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines","volume":"130","author":"Meng","year":"2006","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.prp.2023.154618_bib102","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR\u201021: a small multi\u2010faceted RNA","volume":"13","author":"Krichevsky","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-12","article-title":"miR-21: an oncomir on strike in prostate cancer","volume":"9","author":"Folini","year":"2010","journal-title":"Mol. Cancer"},{"issue":"32","key":"10.1016\/j.prp.2023.154618_bib105","doi-asserted-by":"crossref","first-page":"23716","DOI":"10.1074\/jbc.M701805200","article-title":"miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1","volume":"282","author":"Galardi","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-8-17","article-title":"Molecular assays for the detection of microRNAs in prostate cancer.","volume":"8","author":"Siva","year":"2009","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib107","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1158\/0008-5472.CAN-08-4112","article-title":"The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines","volume":"69","author":"Sun","year":"2009","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2023.154618_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004029","article-title":"The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice","volume":"3","author":"Mercatelli","year":"2008","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib109","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.4161\/cbt.7.8.6284","article-title":"MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer","volume":"7","author":"Rokhlin","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"38","key":"10.1016\/j.prp.2023.154618_bib110","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/onc.2009.192","article-title":"MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation","volume":"28","author":"Lee","year":"2009","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib111","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/abbs\/gmq038","article-title":"MicroRNAs and prostate cancer","volume":"42","author":"Pang","year":"2010","journal-title":"Acta Biochim Biophys. Sin."},{"issue":"50","key":"10.1016\/j.prp.2023.154618_bib112","doi-asserted-by":"crossref","first-page":"19983","DOI":"10.1073\/pnas.0706641104","article-title":"An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells.","volume":"104","author":"Shi","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.prp.2023.154618_bib113","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.onc.1210809","article-title":"Widespread deregulation of microRNA expression in human prostate cancer","volume":"27","author":"Ozen","year":"2008","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.prp.2023.154618_bib114","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","article-title":"MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis","volume":"297","author":"Bloomston","year":"2007","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1261\/rna.2258506","article-title":"RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.","volume":"12","author":"Nelson","year":"2006","journal-title":"Rna"},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib116","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib117","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2353\/ajpath.2006.060480","article-title":"Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma","volume":"169","author":"Chiosea","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib118","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.91.9.3602","article-title":"p53 and E2F-1 cooperate to mediate apoptosis","volume":"91","author":"Wu","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib119","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.clgc.2015.01.003","article-title":"Role of microRNAs in prostate cancer pathogenesis","volume":"13","author":"Wang","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib121","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2019.09.001","article-title":"MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer","volume":"167","author":"Khan","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib122","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41391-017-0023-8","article-title":"The molecular biology of prostate cancer: current understanding and clinical implications","volume":"21","author":"Gandhi","year":"2018","journal-title":"Prostate Cancer prostatic Dis."},{"key":"10.1016\/j.prp.2023.154618_bib123","series-title":"Seminars in Oncology","article-title":"Molecular pathogenesis and progression of prostate cancer","author":"Schrecengost","year":"2013"},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib124","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/pros.22600","article-title":"Upregulation of miR\u2010153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer","volume":"73","author":"Wu","year":"2013","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072400","article-title":"Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1","volume":"8","author":"Haflidad\u00f3ttir","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4161\/cc.26984","article-title":"miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration","volume":"13","author":"Lewis","year":"2014","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009429","article-title":"miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells","volume":"5","author":"Qin","year":"2010","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078023","article-title":"MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases","volume":"8","author":"Arora","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial\u2013mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/1541-7786.MCR-10-0139","article-title":"Mechanisms of motility in metastasizing cells","volume":"8","author":"Yilmaz","year":"2010","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib131","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1007\/s13277-016-4900-x","article-title":"Missing link between microRNA and prostate cancer","volume":"37","author":"Gill","year":"2016","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib132","first-page":"228","article-title":"The role of microRNAs in prostate cancer progression","volume":"2","author":"Lo","year":"2013","journal-title":"Transl. Androl. Urol."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib133","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/pros.22572","article-title":"Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low\u2010risk, localized prostate cancer.","volume":"73","author":"Nguyen","year":"2013","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib134","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.prp.2023.154618_bib135","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/0008-5472.CAN-12-0540","article-title":"miRNA-708 control of CD44+ prostate cancer\u2013initiating cells","volume":"72","author":"Saini","year":"2012","journal-title":"Cancer Res."},{"issue":"31","key":"10.1016\/j.prp.2023.154618_bib136","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1038\/onc.2013.374","article-title":"Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer","volume":"33","author":"Mishra","year":"2014","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib137","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00018-016-2176-3","article-title":"Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches","volume":"73","author":"Doldi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib138","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/ars.2013.5292","article-title":"miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts","volume":"20","author":"Gandellini","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib139","doi-asserted-by":"crossref","first-page":"21414","DOI":"10.3390\/ijms141121414","article-title":"MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer","volume":"14","author":"Kalogirou","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib140","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/bjc.2013.131","article-title":"miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients","volume":"108","author":"Hagman","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"17","key":"10.1016\/j.prp.2023.154618_bib141","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1158\/0008-5472.CAN-13-3718","article-title":"TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression.","volume":"74","author":"Mashima","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib142","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1373\/clinchem.2012.191502","article-title":"Downregulation and prognostic performance of microRNA 224 expression in prostate cancer","volume":"59","author":"Mavridis","year":"2013","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib143","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.juro.2011.11.082","article-title":"miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer","volume":"187","author":"Li","year":"2012","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-208","article-title":"Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy","volume":"8","author":"Sun","year":"2013","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/1078-0432.CCR-12-2952","article-title":"miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways","volume":"19","author":"Majid","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130060","article-title":"Deregulation of MiR-34b\/Sox2 predicts prostate cancer progression","volume":"10","author":"Forno","year":"2015","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib147","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/onc.2015.176","article-title":"A microRNA code for prostate cancer metastasis","volume":"35","author":"Bonci","year":"2016","journal-title":"Oncogene"},{"issue":"36","key":"10.1016\/j.prp.2023.154618_bib148","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016705","article-title":"Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer","volume":"98","author":"Bi","year":"2019","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib149","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41388-018-0450-6","article-title":"The miR-96 and RAR\u03b3 signaling axis governs androgen signaling and prostate cancer progression","volume":"38","author":"Long","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080807","article-title":"The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1","volume":"8","author":"Fendler","year":"2013","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.prp.2023.154618_bib151","doi-asserted-by":"crossref","first-page":"16581","DOI":"10.18632\/oncotarget.15016","article-title":"The role of miR-24 as a race related genetic factor in prostate cancer","volume":"8","author":"Hashimoto","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2023.154618_bib152","doi-asserted-by":"crossref","unstructured":"Nolte, E., et al., miR-24 influences proliferation of prostate cancer cells in vitro via targeting ZNF217. 2013, AACR.","DOI":"10.1158\/1538-7445.AM2013-3090"},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib153","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1158\/1078-0432.CCR-13-1588","article-title":"Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer","volume":"20","author":"Li","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib154","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.3892\/ol.2015.3645","article-title":"miR-34a inhibits cell proliferation in prostate cancer by downregulation of SIRT1 expression","volume":"10","author":"Duan","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2023.154618_bib155","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43511","article-title":"Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"8","author":"Yan","year":"2019","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib156","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/bjc.2013.449","article-title":"The tumour suppressor miR-34c targets MET in prostate cancer cells","volume":"109","author":"Hagman","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib157","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.05.041","article-title":"miR-15a\/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-\u03b2 signaling pathway","volume":"104","author":"Jin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2023.154618_bib158","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.genrep.2018.06.012","article-title":"Functions and epigenetic aspects of miR-15\/16: Possible future cancer therapeutics","volume":"12","author":"Ramaiah","year":"2018","journal-title":"Gene Rep."},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib159","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/cancers10090289","article-title":"miRNA-205 nanoformulation sensitizes prostate cancer cells to chemotherapy","volume":"10","author":"Nagesh","year":"2018","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/ijo.2013.1915","article-title":"MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer","volume":"43","author":"Verdoodt","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2023.154618_bib161","doi-asserted-by":"crossref","unstructured":"Majid, S., et al., Induction of tumor suppressor genes IL24 and IL32 by microRNA-205 in prostate cancer. 2010, AACR.","DOI":"10.1016\/j.juro.2010.02.777"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058929","article-title":"Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer","volume":"8","author":"Chiyomaru","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib163","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/cam4.2029","article-title":"MicroRNA\u2010200a suppresses prostate cancer progression through BRD4\/AR signaling pathway","volume":"8","author":"Guan","year":"2019","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.prp.2023.154618_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083991","article-title":"miR-200b inhibits prostate cancer EMT, growth and metastasis","volume":"8","author":"Williams","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib165","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.02.40","article-title":"MicroRNA-200c-3p\/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0218-y","article-title":"Targeting Wnt\/EZH2\/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer","volume":"5","author":"Shan","year":"2019","journal-title":"Cell death Discov."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib167","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3892\/mmr.2014.2782","article-title":"Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells","volume":"11","author":"Ouyang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1060-z","article-title":"miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKC\u03b5 and ZEB1 inhibition","volume":"38","author":"El Bezawy","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib169","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1530\/REP-17-0322","article-title":"Implications of microRNA dysregulation in the development of prostate cancer","volume":"154","author":"Massillo","year":"2017","journal-title":"Reproduction"},{"issue":"12","key":"10.1016\/j.prp.2023.154618_bib170","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1172\/JCI86505","article-title":"MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression","volume":"126","author":"Dallavalle","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-47234-0","article-title":"Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer","volume":"9","author":"Richardsen","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib172","article-title":"Osseointegrated implants for single tooth replacement: a 1-year report from a multicenter prospective study","volume":"6","author":"Jemt","year":"1991","journal-title":"Int. J. Oral. Maxillofac. Implants"},{"issue":"44","key":"10.1016\/j.prp.2023.154618_bib173","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/onc.2013.451","article-title":"MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32. 31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells","volume":"33","author":"Formosa","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2023.154618_bib174","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"miR-154 inhibits prostate cancer cell proliferation by targeting CCND2","author":"Zhu","year":"2014"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-013-1628-4","article-title":"miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells","volume":"379","author":"Zhu","year":"2013","journal-title":"Mol. Cell. Biochem."},{"issue":"24","key":"10.1016\/j.prp.2023.154618_bib176","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1158\/1078-0432.CCR-14-1784","article-title":"miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer","volume":"20","author":"Gururajan","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"10.1016\/j.prp.2023.154618_bib177","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/onc.2014.212","article-title":"Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis","volume":"34","author":"Josson","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib178","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.18632\/oncotarget.23026","article-title":"MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression","volume":"9","author":"Fu","year":"2018","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib179","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.febslet.2015.04.037","article-title":"MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1","volume":"589","author":"Lu","year":"2015","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib180","first-page":"5291","article-title":"miR\u201127a in serum acts as biomarker for prostate cancer detection and promotes cell proliferation by targeting Sprouty2","volume":"16","author":"Gao","year":"2018","journal-title":"Oncol. Lett."},{"issue":"14","key":"10.1016\/j.prp.2023.154618_bib181","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1093\/hmg\/dds139","article-title":"Androgen-regulated processing of the oncomir miR-27a, which targets prohibitin in prostate cancer","volume":"21","author":"Fletcher","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.prp.2023.154618_bib182","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biocel.2016.08.043","article-title":"Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression","volume":"79","author":"Wan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib183","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pros.21270","article-title":"miR\u2010125b promotes growth of prostate cancer xenograft tumor through targeting pro\u2010apoptotic genes","volume":"71","author":"Shi","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.prp.2023.154618_bib184","doi-asserted-by":"crossref","unstructured":"Aherne, S.T., et al., miR-125 family of miRNAs mediates prostate cancer cell proliferation and migration. 2016, AACR.","DOI":"10.1158\/1538-7445.AM2016-1091"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib185","first-page":"1889","article-title":"MicroRNA\u2011135a induces prostate cancer cell apoptosis via inhibition of STAT6","volume":"17","author":"Xu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"22","key":"10.1016\/j.prp.2023.154618_bib186","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1038\/onc.2014.222","article-title":"Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2","volume":"34","author":"Kroiss","year":"2015","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.prp.2023.154618_bib187","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1007\/s13277-016-5196-6","article-title":"hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR","volume":"37","author":"Xu","year":"2016","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib188","first-page":"1","article-title":"MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065064","article-title":"Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer","volume":"8","author":"Schubert","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033729","article-title":"Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM","volume":"7","author":"Kong","year":"2012","journal-title":"PloS One"},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib191","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1158\/0008-5472.CAN-11-3864","article-title":"Distinct microRNA expression profiles in prostate cancer stem\/progenitor cells and tumor-suppressive functions of let-7","volume":"72","author":"Liu","year":"2012","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.prp.2023.154618_bib192","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/bjc.2016.95","article-title":"Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer","volume":"114","author":"Goto","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib193","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.2147\/OTT.S102862","article-title":"Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301","volume":"9","author":"Han","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"41","key":"10.1016\/j.prp.2023.154618_bib194","doi-asserted-by":"crossref","first-page":"67597","DOI":"10.18632\/oncotarget.11708","article-title":"MicroRNAs and epithelial-mesenchymal transition in prostate cancer","volume":"7","author":"Sekhon","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ijc.28707","article-title":"MicroRNA\u2010224 inhibits progression of human prostate cancer by downregulating TRIB1","volume":"135","author":"Lin","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.prp.2023.154618_bib196","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.febslet.2014.04.020","article-title":"Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer","volume":"588","author":"Goto","year":"2014","journal-title":"FEBS Lett."},{"issue":"16","key":"10.1016\/j.prp.2023.154618_bib197","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1200\/JCO.2006.09.0795","article-title":"Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas","volume":"25","author":"Birrer","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib198","first-page":"9051","article-title":"MicroRNA\u2011126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9","volume":"15","author":"Hua","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib199","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3892\/mmr.2015.4661","article-title":"MicroRNA\u2011126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer","volume":"13","author":"Song","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.apjtm.2016.09.011","article-title":"miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: An experimental study","volume":"10","author":"Yang","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib201","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/15384047.2019.1599659","article-title":"Upregulation of MicroRNA-21 promotes tumorigenesis of prostate cancer cells by targeting KLF5","volume":"20","author":"Guan","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib202","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5732\/cjc.30.0371","article-title":"Apoptosis and the target genes of microRNA-21","volume":"30","author":"Buscaglia","year":"2011","journal-title":"Chin. J. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib203","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201541","article-title":"Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection","volume":"218","author":"Caiado","year":"2021","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib204","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","article-title":"Genetic and non-genetic clonal diversity in cancer evolution","volume":"21","author":"Black","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103495","article-title":"Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice","volume":"167","author":"Oey","year":"2021","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.prp.2023.154618_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114117","article-title":"Romero, Biomedical application of small extracellular vesicles in cancer treatment","author":"Araujo-Abad","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib207","first-page":"296","article-title":"Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies","volume":"25","author":"Margolis","year":"2022"},{"key":"10.1016\/j.prp.2023.154618_bib208","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fgene.2023.1065757","article-title":"Urinary extracellular vesicles miRNA\u2014A new era of prostate cancer biomarkers","volume":"14","author":"Jain","year":"2023","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib209","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s10753-021-01415-0","article-title":"MicroRNA 21 elicits a pro-inflammatory response in macrophages, with exosomes functioning as delivery vehicles","volume":"44","author":"Madhyastha","year":"2021","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell\u2013cell communication by extracellular vesicles","volume":"23","author":"van Niel","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2023.154618_bib211","unstructured":"Ero\u011flu, F.K., Characterization of Functional and Molecular Properties of Circulating Extracellular Vesicles of Childhood Idiopathic Nephrotic Syndrome Patients. 2021, Bilkent Universitesi (Turkey)."},{"key":"10.1016\/j.prp.2023.154618_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111528","article-title":"MicroRNA: A signature for cancer progression","volume":"138","author":"Hussen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"0)","key":"10.1016\/j.prp.2023.154618_bib213","article-title":"The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review. Future","author":"Vazquez-Urrutia","year":"2023","journal-title":"Oncology"},{"key":"10.1016\/j.prp.2023.154618_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.679527","article-title":"Emerging role of exosomes in liquid biopsy for monitoring prostate cancer invasion and metastasis","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2023.154618_bib215","series-title":"Seminars in Cancer Biology","article-title":"Exosomes and prostate cancer management. in","author":"Vlaeminck-Guillem","year":"2021"},{"issue":"9","key":"10.1016\/j.prp.2023.154618_bib216","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3390\/cells10092372","article-title":"A new approach for prostate cancer diagnosis by miRNA profiling of prostate-derived plasma small extracellular vesicles","volume":"10","author":"Zabegina","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib217","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41416-021-01598-1","article-title":"Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients","volume":"126","author":"Ramirez-Garrastacho","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.prp.2023.154618_bib218","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.3390\/ijms23137134","article-title":"Isolation and characterization of urinary extracellular vesicles from healthy donors and patients with castration-resistant prostate cancer","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154618_bib219","first-page":"1","article-title":"Diagnostic and prognostic significance of extracellular vesicles in prostate cancer drug resistance: A systematic review of the literature","author":"Grimaldi","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"18","key":"10.1016\/j.prp.2023.154618_bib220","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.3390\/cancers13184608","article-title":"Extracellular vesicle-associated miRNAs and chemoresistance: a systematic review","volume":"13","author":"Campos","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154618_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119005","article-title":"The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators","volume":"268","author":"Mirzaei","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2023.154618_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153851","article-title":"Molecular landscape of c-Myc signaling in prostate cancer: a roadmap to clinical translation","author":"Faskhoudi","year":"2022","journal-title":"Pathol. -Res. Pract."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib223","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/andr.13086","article-title":"The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors","volume":"10","author":"Konoshenko","year":"2022","journal-title":"Andrology"},{"key":"10.1016\/j.prp.2023.154618_bib224","first-page":"63","article-title":"MicroRNAs as potential liquid biopsy biomarker for patients with castration-resistant prostate cancer","volume":"14","author":"Fernandez","year":"2022","journal-title":"Res. Rep. Urol."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/andr.12921","article-title":"miRNAs and radiotherapy response in prostate cancer","volume":"9","author":"Konoshenko","year":"2021","journal-title":"Andrology"},{"key":"10.1016\/j.prp.2023.154618_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.humgen.2022.201081","article-title":"Implication of circulating microRNA-21 as a potential non-invasive diagnostic predictor of prostate cancer patients","volume":"34","author":"Ahmed","year":"2022","journal-title":"Hum. Gene"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-021-00190-9","article-title":"MicroRNAs as the critical regulators of protein kinases in prostate and bladder cancers","volume":"22","author":"Zangoue","year":"2021","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"17","key":"10.1016\/j.prp.2023.154618_bib228","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.3390\/cancers13174492","article-title":"Role of metastasis-related microRNAs in prostate cancer progression and treatment","volume":"13","author":"Oh-Hohenhorst","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib229","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/bjc.2011.595","article-title":"Changes in circulating microRNA levels associated with prostate cancer","volume":"106","author":"Bryant","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fgene.2013.00036","article-title":"Exosomal miRNAs as biomarkers for prostate cancer","volume":"4","author":"Hessvik","year":"2013","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib231","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10142-022-00951-8","article-title":"Exosomal miRNAs\u2014a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer","volume":"23","author":"Chowdhury","year":"2023","journal-title":"Funct. Integr. Genom."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib232","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10142-022-00951-8","article-title":"Exosomal miRNAs-a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer","volume":"23","author":"Chowdhury","year":"2022","journal-title":"Funct. Integr. Genom."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib233","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/ijms17030421","article-title":"MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer","volume":"17","author":"Bertoli","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib234","doi-asserted-by":"crossref","first-page":"9927","DOI":"10.1002\/jcp.27948","article-title":"The role of microRNAs in prostate cancer migration, invasion, and metastasis","volume":"234","author":"Aghdam","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib235","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/ijms20051154","article-title":"Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 expression as biomarker for prostate cancer diagnosis","volume":"20","author":"Moya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib236","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/s1677-5538.ibju.2019.0409","article-title":"Role of miRNA-182 and miRNA-187 as potential biomarkers in prostate cancer and its correlation with the staging of prostate cancer","volume":"46","author":"Nayak","year":"2020","journal-title":"Int. Braz. J. Urol."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib237","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/diagnostics10040188","article-title":"Profiling of circulating microRNAs in prostate cancer reveals diagnostic biomarker potential","volume":"10","author":"Freds\u00f8e","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.prp.2023.154618_bib238","doi-asserted-by":"crossref","unstructured":"Alhasan, A.H., et al., Circulating microRNA signature for the diagnosis of very high-risk prostate cancer. Proceedings of the National Academy of Sciences, 2016. 113(38): p. 10655\u201310660.","DOI":"10.1073\/pnas.1611596113"},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib239","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/jcm4071369","article-title":"A circulating microRNA signature as a biomarker for prostate cancer in a high risk group","volume":"4","author":"Kelly","year":"2015","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/dna.2014.2663","article-title":"Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer","volume":"34","author":"Kachakova","year":"2015","journal-title":"DNA Cell Biol."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib241","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1530\/ERC-14-0234","article-title":"Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers","volume":"21","author":"Selth","year":"2014","journal-title":"Endocr. -Relat. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2023.154618_bib242","first-page":"14335","article-title":"Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib243","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3390\/ijms24031980","article-title":"The role of different types of microRNA in the pathogenesis of breast and prostate cancer","volume":"24","author":"Sidorova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2023.154618_bib244","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fonc.2019.01473","article-title":"MicroRNA-99a suppresses breast cancer progression by targeting FGFR3","volume":"9","author":"Long","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-24424-w","article-title":"A plasma biomarker panel of four microRNAs for the diagnosis of prostate cancer","volume":"8","author":"Matin","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib246","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.juro.2014.01.107","article-title":"Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy","volume":"192","author":"Casanova-Salas","year":"2014","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib247","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69290-7","article-title":"Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis","volume":"10","author":"Parra-Medina","year":"2020","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.prp.2023.154618_bib248","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmcl.2016.10.042","article-title":"MiR-106a: promising biomarker for cancer","volume":"26","author":"Pan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36854-7","article-title":"MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer","volume":"9","author":"Richardsen","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib250","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.afju.2018.11.006","article-title":"microRNA-141 as a diagnostic and prognos-tic biomarker for prostate cancer in Egyptian population: Pilot study","volume":"24","author":"Ali","year":"2018","journal-title":"Afr. J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01186-6","article-title":"microRNAs identified in prostate cancer: correlative studies on response to ionizing radiation","volume":"19","author":"Labb\u00e9","year":"2020","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib252","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.prnil.2014.09.001","article-title":"Prognostic role of microRNA-145 in prostate cancer: a systems review and meta-analysis","volume":"3","author":"Zhang","year":"2015","journal-title":"Prostate Int."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib253","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6605742","article-title":"The functional significance of microRNA-145 in prostate cancer","volume":"103","author":"Zaman","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2023.154618_bib254","doi-asserted-by":"crossref","unstructured":"Benedetti, I., J. Rebollo, and N. Reyes, miR155 and miR9 expression in human prostate cancer cell lines and prostate cancer tissue. 2018, AACR.","DOI":"10.1158\/1538-7445.AM2018-5412"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3892\/ol.2017.6163","article-title":"Low expression of microRNA\u201130c promotes prostate cancer cells invasion involved in downregulation of KRAS protein","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib256","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s13577-017-0170-1","article-title":"MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1","volume":"30","author":"Zhu","year":"2017","journal-title":"Hum. Cell"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib257","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-10-1031","article-title":"miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation","volume":"71","author":"Sun","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2023.154618_bib258","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.omto.2020.03.024","article-title":"Ectopic expression of miR-532-3p suppresses bone metastasis of prostate cancer cells via inactivating NF-\u03baB Signaling","volume":"17","author":"Wa","year":"2020","journal-title":"Mol. Ther. -Oncolytics"},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib259","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000504606","article-title":"miR-1231 is downregulated in prostate cancer with prognostic and functional implications","volume":"43","author":"Wang","year":"2020","journal-title":"Oncol. Res. Treat."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib260","first-page":"6187","article-title":"Predictive values of miR\u2011129 and miR\u2011139 for efficacy on patients with prostate cancer after chemotherapy and prognostic correlation","volume":"18","author":"Hu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib261","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3892\/ijo.2017.4038","article-title":"Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis","volume":"51","author":"Chen","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib262","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.3892\/mmr.2016.5859","article-title":"miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma","volume":"14","author":"Xu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib263","first-page":"8394","article-title":"Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"21","key":"10.1016\/j.prp.2023.154618_bib264","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1158\/1078-0432.CCR-15-0217","article-title":"miR-195 inhibits tumor progression by targeting RPS6KB1 in human prostate cancer","volume":"21","author":"Cai","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-015-0209-7","article-title":"MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma","volume":"34","author":"Guo","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154618_bib266","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/jca.11038","article-title":"Controlling RECK miR21 promotes tumor cell invasion and is related to biochemical recurrence in prostate cancer","volume":"6","author":"Leite","year":"2015","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2023.154618_bib267","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/pros.23871","article-title":"MicroRNA\u2010139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL","volume":"79","author":"Nam","year":"2019","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib268","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13402-019-00486-4","article-title":"The exosomal integrin \u03b15\u03b21\/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration","volume":"43","author":"Li","year":"2020","journal-title":"Cell. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib269","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2490-12-14","article-title":"miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer","volume":"12","author":"Reis","year":"2012","journal-title":"BMC Urol."},{"issue":"10","key":"10.1016\/j.prp.2023.154618_bib270","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/thno.11543","article-title":"MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer","volume":"5","author":"Bertoli","year":"2015","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.prp.2023.154618_bib271","doi-asserted-by":"crossref","first-page":"eaay3051","DOI":"10.1126\/sciadv.aay3051","article-title":"miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1","volume":"6","author":"Urabe","year":"2020","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib272","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.7150\/jca.41888","article-title":"MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1","volume":"11","author":"Tan","year":"2020","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib273","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/cells9020435","article-title":"miR-1272 exerts tumor-suppressive functions in prostate cancer via HIP1 suppression","volume":"9","author":"Rotundo","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib274","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/mt.2009.207","article-title":"Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes","volume":"18","author":"Takeshita","year":"2010","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib275","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4161\/cc.10.7.15180","article-title":"MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines","volume":"10","author":"Viticchi\u00e8","year":"2011","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12222","article-title":"Regulation of angiogenesis by microRNAs in cancer","volume":"24","author":"Zheng","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib277","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12094-019-02217-5","article-title":"MiR-130b\/TNF-\u03b1\/NF-\u03baB\/VEGFA loop inhibits prostate cancer angiogenesis","volume":"22","author":"Mu","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib278","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0615-x","article-title":"MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1\/c-JUN\/VEGFA pathway and predicts aggressive outcome in prostate cancer","volume":"16","author":"Lin","year":"2017","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154618_bib279","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010147","article-title":"MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2","volume":"5","author":"Dong","year":"2010","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.prp.2023.154618_bib280","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajpath.2014.01.017","article-title":"miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment","volume":"184","author":"Qu","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2023.154618_bib281","first-page":"1","article-title":"MicroRNA-143 inhibits proliferation and migration of prostate cancer cells","author":"Bajhan","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib282","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154618_bib283","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1093\/nar\/gkv273","article-title":"A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation","volume":"43","author":"Hatano","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.prp.2023.154618_bib284","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1667\/RR14185.1","article-title":"MicroRNA-145 modulates tumor sensitivity to radiation in prostate cancer","volume":"184","author":"Gong","year":"2015","journal-title":"Radiat. Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2008.09.086","article-title":"Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells","volume":"377","author":"Fujita","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.prp.2023.154618_bib286","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/pros.21185","article-title":"MiR\u201034a attenuates paclitaxel\u2010resistance of hormone\u2010refractory prostate cancer PC3 cells through direct and indirect mechanisms","volume":"70","author":"Kojima","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.prp.2023.154618_bib287","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2019.12.025","article-title":"miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA","volume":"473","author":"Ray","year":"2020","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.prp.2023.154618_bib288","doi-asserted-by":"crossref","first-page":"13894","DOI":"10.18632\/oncotarget.24532","article-title":"Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer","volume":"9","author":"Panigrahi","year":"2018","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.prp.2023.154618_bib289","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/pros.20827","article-title":"Radiation modulation of microRNA in prostate cancer cell lines","volume":"68","author":"Josson","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.prp.2023.154618_bib290","first-page":"639","article-title":"MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1","volume":"24","author":"Chen","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib291","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21691401.2018.1553783","article-title":"MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF","volume":"47","author":"Zhao","year":"2019","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib292","first-page":"539","article-title":"miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2","volume":"23","author":"Fan","year":"2019","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.prp.2023.154618_bib293","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.omtn.2019.01.004","article-title":"miR-582-3p and miR-582-5p suppress prostate cancer metastasis to bone by repressing TGF-\u03b2 signaling","volume":"16","author":"Huang","year":"2019","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.prp.2023.154618_bib294","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2018.02.036","article-title":"Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer","volume":"654","author":"Chang","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.prp.2023.154618_bib295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109428","article-title":"Functions and mechanisms of miR-186 in human cancer","volume":"119","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib296","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2015.05.003","article-title":"A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA","volume":"365","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.prp.2023.154618_bib297","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/bib\/bbx130","article-title":"MicroRNAs and complex diseases: from experimental results to computational models","volume":"20","author":"Chen","year":"2019","journal-title":"Brief. Bioinforma."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib298","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00335-009-9241-2","article-title":"Computational approaches for microRNA studies: a review","volume":"21","author":"Li","year":"2010","journal-title":"Mamm. Genome"},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib299","first-page":"47","article-title":"MicroRNA-small molecule association identification: from experimental results to computational models","volume":"21","author":"Chen","year":"2020","journal-title":"Brief. Bioinforma."},{"issue":"7","key":"10.1016\/j.prp.2023.154618_bib300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007209","article-title":"Ensemble of decision tree reveals potential miRNA-disease associations","volume":"15","author":"Chen","year":"2019","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154618_bib301","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/bib\/bbz159","article-title":"NCMCMDA: miRNA\u2013disease association prediction through neighborhood constraint matrix completion","volume":"22","author":"Chen","year":"2021","journal-title":"Brief. Bioinforma."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:46:36Z","timestamp":1774410396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":301,"alternative-id":["S0344033823003187"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154618","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154618"}}